Highlights in the Discovery of Antiviral Drugs: A Personal Retrospective

被引：109

作者：

De Clercq, Erik ^{[1
]}

机构：

[1] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2010年 / 53卷 / 04期

关键词：

ACYCLIC NUCLEOSIDE PHOSPHONATES; HUMAN-IMMUNODEFICIENCY-VIRUS; VARICELLA-ZOSTER-VIRUS; HEPATITIS-B VIRUS; ANTI-HIV DRUG; TRANSCRIPTASE INHIBITORS NNRTIS; NON-HODGKINS-LYMPHOMA; 4,5,6,7-TETRAHYDRO-5-METHYLIMIDAZO<4,5,1-JK><1,4>BENZODIAZEPIN-2(1H)-ONE TIBO DERIVATIVES; HEMATOPOIETIC PROGENITOR CELLS; FIBROBLAST INTERFERON GENE;

D O I：

10.1021/jm900932g

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：1438 / 1450

页数：13

共 115 条

[1]

Andrei G, 1998, ONCOL RES, V10, P523

[2] Susceptibilities of several clinical Varicella-zoster virus (VZV) isolates and drug-resistant VZV strains to bicyclic furano pyrimidine nucleosides [J].

Andrei, G ;

Sienaert, R ;

McGuigan, C ;

De Clercq, E ;

Balzarini, J ;

Snoeck, R .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (03) :1081-1086

[3] TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1 [J].

Andries, K ;

Azijn, H ;

Thielemans, T ;

Ludovici, D ;

Kukla, M ;

Heeres, J ;

Janssen, P ;

De Corte, B ;

Vingerhoets, J ;

Pauwels, R ;

de Béthune, MP .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) :4680-4686

[4] PRECLINICAL EVALUATION OF MKC-442, A HIGHLY POTENT AND SPECIFIC INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN-VITRO [J].

BABA, M ;

SHIGETA, S ;

YUASA, S ;

TAKASHIMA, H ;

SEKIYA, K ;

UBASAWA, M ;

TANAKA, H ;

MIYASAKA, T ;

WALKER, RT ;

DECLERCQ, E .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (04) :688-692

[5] HIGHLY SPECIFIC-INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 BY A NOVEL 6-SUBSTITUTED ACYCLOURIDINE DERIVATIVE [J].

BABA, M ;

TANAKA, H ;

DECLERCQ, E ;

PAUWELS, R ;

BALZARINI, J ;

SCHOLS, D ;

NAKASHIMA, H ;

PERNO, CF ;

WALKER, RT ;

MIYASAKA, T .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 165 (03) :1375-1381

[6] Antiretrovirus activity of a novel class of acyclic pyrimidine nucleoside phosphonates [J].

Balzarini, J ;

Pannecouque, C ;

De Clercq, E ;

Aquaro, S ;

Perno, CF ;

Egberink, H ;

Holy, A .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (07) :2185-2193

[7] DIFFERENTIAL ANTIHERPESVIRUS AND ANTIRETROVIRUS EFFECTS OF THE (S) AND (R) ENANTIOMERS OF ACYCLIC NUCLEOSIDE PHOSPHONATES - POTENT AND SELECTIVE INVITRO AND INVIVO ANTIRETROVIRUS ACTIVITIES OF (R)-9-(2-PHOSPHONOMETHOXYPROPYL)-2,6-DIAMINOPURINE [J].

BALZARINI, J ;

HOLY, A ;

JINDRICH, J ;

NAESENS, L ;

SNOECK, R ;

SCHOLS, D ;

DECLERCQ, E .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (02) :332-338

[8] Synthesis and antiviral evaluation of alkoxyalkyl derivatives of 9-(S)-(3-hydroxy-2-phosphonomethoxypropyl)adenine against cytomegalovirus and orthopoxviruses [J].

Beadle, JR ;

Wan, WB ;

Ciesla, SL ;

Keith, KA ;

Hartline, C ;

Kern, ER ;

Hostetler, KY .

JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (06) :2010-2015

[9] Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist [J].

Broxmeyer, HE ;

Orschell, CM ;

Clapp, DW ;

Hangoc, G ;

Cooper, S ;

Plett, PA ;

Liles, WC ;

Li, XX ;

Graham-Evans, B ;

Campbell, TB ;

Calandra, G ;

Bridger, G ;

Dale, DC ;

Srour, EF .

JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (08) :1307-1318

[10] AMD3100 plus G-CSF can successfully mobilize CD34+cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data [J].

Calandra, G. ;

McCarty, J. ;

McGuirk, J. ;

Tricot, G. ;

Crocker, S-A ;

Badel, K. ;

Grove, B. ;

Dye, A. ;

Bridger, G. .

BONE MARROW TRANSPLANTATION, 2008, 41 (04) :331-338

← 1 2 3 4 5 6 7 8 9 10 →